Concepedia

Christoph Kalis

CK

Statistics

Publications

15

Citations

2.4K

H-Index

14

Active since

2002

Affiliations

Max Planck Institute of Immunobiology and Epigenetics(Current)

Max Planck Society

University of Freiburg

University Medical Center Freiburg

Scripps Research Institute

Christoph Kalis is an author at Max Planck Institute of Immunobiology and Epigenetics specializing in immunology, innate immunity, and life sciences.

Publications per year

2002–2018

15

Publications

15

CD14 is required for MyD88-independent LPS signaling

Zhengfan Jiang, Philippe Georgel, Xin Du et al. · Nature Immunology · 2005 · 675 citations

, , +10

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel

Marc Schmidt, Badrinarayanan Raghavan, Verena Müller et al. · Nature Immunology · 2010 · 585 citations

, , +16

Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm et al. · Blood · 2017 · 286 citations · Full text

, , +10

R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells

Michael Huber, Christoph Kalis, Simone Keck et al. · European Journal of Immunology · 2006 · 174 citations · Full text

, , +17

Cutting Edge: A Murine, IL-12-Independent Pathway of IFN-γ Induction by Gram-Negative Bacteria Based on STAT4 Activation by Type I IFN and IL-18 Signaling

Marina A. Freudenberg, Thomas Merlin, Christoph Kalis et al. · The Journal of Immunology · 2002 · 120 citations

, , +17

1–5 of 15